ES2087160T3 - Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos. - Google Patents

Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.

Info

Publication number
ES2087160T3
ES2087160T3 ES90911873T ES90911873T ES2087160T3 ES 2087160 T3 ES2087160 T3 ES 2087160T3 ES 90911873 T ES90911873 T ES 90911873T ES 90911873 T ES90911873 T ES 90911873T ES 2087160 T3 ES2087160 T3 ES 2087160T3
Authority
ES
Spain
Prior art keywords
inflammatory
compositions
treatment
painful
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911873T
Other languages
English (en)
Inventor
Joel E Bernstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cisco LP
Original Assignee
Cisco LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cisco LP filed Critical Cisco LP
Application granted granted Critical
Publication of ES2087160T3 publication Critical patent/ES2087160T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

COMPOSICIONES Y METODO PARA EL TRATAMIENTO DE TRASTORNOS DOLOROSOS, INFLAMATORIOS Y ALERGICOS LA INVENCION SE REFIERE A UN METODO PARA EL TRATAMIENTO DE TRASTORNOS DOLOROSOS, INFLAMATORIOS O ALERGICOS QUE CONSISTE EN TRATARLOS CON UNA CANTIDAD EFECTIVA DE UNA COMPOSICION QUE CONTIENE CIS-8-METIL-N-VANILLIL-6-NONENAMIDA. LA INVENCION SE REFIERE TAMBIEN A COMPOSICIONES PARA UTILIZARLAS CON EL METODO DE LA INVENCION.
ES90911873T 1989-12-19 1990-06-28 Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos. Expired - Lifetime ES2087160T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/452,476 US5063060A (en) 1989-12-19 1989-12-19 Compositions and method for treating painful, inflammatory or allergic disorders

Publications (1)

Publication Number Publication Date
ES2087160T3 true ES2087160T3 (es) 1996-07-16

Family

ID=23796595

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911873T Expired - Lifetime ES2087160T3 (es) 1989-12-19 1990-06-28 Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.

Country Status (13)

Country Link
US (1) US5063060A (es)
EP (1) EP0506658B1 (es)
JP (1) JPH0780761B2 (es)
KR (1) KR950015056B1 (es)
AT (1) ATE138567T1 (es)
AU (1) AU645023B2 (es)
CA (1) CA2070685C (es)
DE (1) DE69027220T2 (es)
DK (1) DK0506658T3 (es)
ES (1) ES2087160T3 (es)
IL (1) IL95820A (es)
RU (1) RU2095060C1 (es)
WO (1) WO1991008738A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508975A (ja) * 1992-04-23 1995-10-05 バーレックス　ラボラトリーズ　インコーポレイテッド 生体接着性水性鉱油エマルション軟膏基剤，それからなる局所医薬組成物及び創傷治癒におけるその使用
US6063381A (en) * 1993-05-19 2000-05-16 Staggs; Jeff J. Therapeutic uses of pungent botanicals and their related compounds
US6635659B1 (en) * 1995-03-20 2003-10-21 Arrie Kegler Topical formulation for arthritic symptoms treatment
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US5840762A (en) * 1996-01-12 1998-11-24 Genderm Corporation Method for the treatment of cardiac arrhythmias and shortening of action potential duration
DE19622271A1 (de) * 1996-06-03 1997-12-04 Basf Ag Chirale Verbindungen
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
JP4677063B2 (ja) * 1997-07-18 2011-04-27 帝國製薬株式会社 オランダカラシエキス配合外用製剤
US6284797B1 (en) * 1999-04-12 2001-09-04 Donald A. Rhodes Topical treatment of pain and to promote healing
JP2006513267A (ja) * 2002-12-18 2006-04-20 アルゴルクス ファーマスーティカルズ，インク カプサイシノイドの投与
WO2004056305A2 (en) * 2002-12-18 2004-07-08 Algorx Administration of capsaicinoids
US20040146464A1 (en) * 2003-01-23 2004-07-29 Bernstein Joel E. Compositions and method for daily tooth and gum care
US20050085552A1 (en) * 2003-10-16 2005-04-21 Winston Laboratories, Inc. Method for providing long-lasting pain relief through intrathecal administration of civamide
US7244446B2 (en) * 2003-10-16 2007-07-17 Winston Laboratories, Inc. Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide
EP1772065B1 (en) * 2004-06-15 2012-11-28 Ajinomoto Co., Inc. Dried capsicum containing capsinoid and method of drying therefor
JPWO2007013690A1 (ja) * 2005-07-28 2009-02-12 味の素株式会社 顧客に適する局所塗布剤とサプリメントとを提供する方法
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
US20110014269A1 (en) * 2009-07-14 2011-01-20 Winston Laboratories, Inc. Civamide patch for localized post-incisional neuropathic pain
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460602A (en) * 1981-06-30 1984-07-17 The Procter & Gamble Company Urea derivatives
US4546112A (en) * 1981-12-14 1985-10-08 The Procter & Gamble Company Method for preventing or reducing dipilatory irritation
US4536404A (en) * 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4702916A (en) * 1985-12-03 1987-10-27 Warner-Lambert Company Analgesic stick compositions

Also Published As

Publication number Publication date
EP0506658A1 (en) 1992-10-07
AU6064890A (en) 1991-07-18
US5063060A (en) 1991-11-05
WO1991008738A1 (en) 1991-06-27
KR950015056B1 (ko) 1995-12-21
DE69027220T2 (de) 1997-01-02
JPH0780761B2 (ja) 1995-08-30
IL95820A (en) 1996-08-04
DK0506658T3 (da) 1996-06-24
DE69027220D1 (de) 1996-07-04
CA2070685A1 (en) 1991-06-20
EP0506658B1 (en) 1996-05-29
KR920703041A (ko) 1992-12-17
AU645023B2 (en) 1994-01-06
JPH05504546A (ja) 1993-07-15
RU2095060C1 (ru) 1997-11-10
EP0506658A4 (en) 1993-03-03
CA2070685C (en) 1994-11-01
ATE138567T1 (de) 1996-06-15

Similar Documents

Publication Publication Date Title
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
BR9509498A (pt) Agente aglutinante uso do mesmo composição farmacêutica e processo para tratamento de uma doença inflamatória autoimune ou uma doença alérgica
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
ZA848512B (en) Reducing sebum spreading
BR9000990A (pt) Composicao aquosa condicionadora de tecidos e processo para o tratamento de tecidos
DE68917071T2 (de) Mittel zur stimulierung der tränensekretion.
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE69114470T2 (de) Komposition für die behandlung von augenschmerzen.
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69123363D1 (de) Neue zusammensetzungen
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
BR8901135A (pt) Composicao para condicionamento de tecido e processo para tratar tecidos
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
MX9100179A (es) Composicion y metodo para el tratamiento de disfunciones neurologicas en mamiferos
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
BR9500886A (pt) Composições com efeito regulador de crescimento e método para o tratamento de culturas
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ES2098030T3 (es) Nuevos agentes cardioprotectores.
BR9509727A (pt) Processo de tratamento oral composição oral para tratar uma superfície oral uso e agente de tratamento oral
ES2100941T3 (es) Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias.
BR8205141A (pt) Composicao acaricida e processo para tratamento de infestacoes de acaros em plantas uteis
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0506658

Country of ref document: ES